Anaptysbio (ANAB) Capital Expenditures Growth (3y) (2019 - 2026)
Anaptysbio (ANAB) Capital Expenditures Growth (3y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Anaptysbio |
1.66 Bn |
1.38 Bn |
- |
-54.03% |
| Date | Value |
|---|
| Mar 31, 2026 |
-54.03% |
| Dec 31, 2025 |
-80.05% |
| Sep 30, 2025 |
28.35% |
| Jun 30, 2025 |
-30.06% |
| Mar 31, 2025 |
22.59% |
| Dec 31, 2024 |
136.03% |
| Sep 30, 2024 |
26.62% |
| Jun 30, 2024 |
-66.31% |
| Mar 31, 2024 |
-56.00% |
| Dec 31, 2023 |
9.33% |
| Sep 30, 2023 |
261.90% |
| Jun 30, 2023 |
-51.31% |
| Mar 31, 2023 |
26.72% |
| Dec 31, 2022 |
-44.14% |
| Sep 30, 2022 |
-52.46% |
| Jun 30, 2022 |
36.09% |
| Mar 31, 2022 |
-56.64% |
| Dec 31, 2021 |
26.59% |
| Sep 30, 2021 |
-55.54% |
| Jun 30, 2021 |
66.49% |
